logo/base Created with Sketch.
Download the brochure

Guided VCTE®

Seamless liver health assessment for all

As a leader in liver health, we have elevated our core liver elastography technology to the next level with the introduction of Guided VCTE® – our Next-Generation FibroScan® technology.

chevron chevron

Faster examinations with improved guidance

Guided VCTE® indicators

Two new visual indicators allow operators to quickly identify the optimal measurement location.1 Computed by a continuous vibration of the probe transducer, these indicators intuitively guide the operator throughout the entire duration of the exam.

Time savings for all adult patient morphologies

With Guided VCTE®, 96% of patients can be scanned in less than 4 minutes, including patients with BMI≥35.

AutoScan: New efficiency feature

Based on the Guided VCTE® indicators, AutoScan automatically triggers 10 valid measurements through a single click, enabling streamlined scanning and a likely improved operator experience.

Discover in video

Technology Spotlight Webinar: How Guided VCTE® Can Optimize Operator & Physician Experience

In this webinar, hear from key leaders in liver health detail their experience using the next-generation FibroScan® system, equipped with new Guided VCTE® technology.

Learn more about how this technology impacts both the operator and physician experience, with a focus on optimizing liver health management through efficiency and standardization.

Watch the replay

The Technology Behind Guided VCTE®

This white paper provides a technology overview of Guided VCTE® and its associated benefits.

Download the white paper

Our liver health solutions

  • FibroScan® Mini+ 430

    FibroScan® by echosens

    The non-invasive solution for comprehensive management of liver health

    chevron
  • Liver Health Management

    Liver Health Management

    Cloud-based solution to assist clinicians in providing comprehensive liver care.

    chevron
  • FibroScan® Gateway

    FibroScan® Gateway

    Optimize clinical workflows with real-time secure data transmission

    chevron

  • myFibroScan

    Your everyday FibroScan® companion – free application

    chevron

Guided VCTE® is endorsed by healthcare professionals

Guided VCTE helps improve operator efficiency and perhaps standardize their performance. We expect that Guided VCTE features will improve the reliability of LSM without prolonging the study duration, even in patients with MASLD.

Dr. Raj Vuppalanchi

Professor of Medicine, Director of Hepatology and Associate Program Director | Indiana University School of Medicine

Guided VCTE technology has significantly improved the operator’s confidence that the probe is in the right place over the liver, excluding either lung or rib artifact. This will also enhance reliability when performing sequential scans on the same patient.

Dr. Martin Grajower

MD, FACP, FACE | Endocrinologist, Clinical Professor of Medicine | Albert Einstein College of Medicine

The addition of Guided VCTE is practice changing as it provides benefits to the provider and operator. Our clinical practice is able to be more efficient with the combination of a faster scan, providing my operators with easier localization and consistent measurements. The new reports contain a more refined image facilitating my interpretations. Guided VCTE has augmented both our comfort and confidence in measurement accuracy when diagnosing our patients with liver disease.

Dr. Tejas Joshi

Hepatologist, Director of Liver Diseases & Associate Professor | Marshall University School of Medicine

Watch our operators' perspective in video chevron

Request a demo!

Interested in FibroScan®?

Contact us

* Without SmartExam, the maximum recommended Probe-to-Capsula distance (PCD) is 35 mm. With SmartExam, it is 45mm, representing an increase of 28%.

References

1. Bastard, Cécile et al. “Guided-VCTE: An Enhanced FibroScan Examination With Improved Guidance and Applicability.” Ultrasound in medicine & biology vol. 51,4 (2025): 628-637.
2. E. Bardou-Jacquet et al. Validation of the Continuous Controlled Attenuation Parameter (CAPc) using the MRI-PDFF as reference. EASL 2022 poster #FRI-228.

The FibroScan® device (Models: 430 Mini+, 530 Compact and 630 Expert) is intended to measure liver stiffness (E) using Vibration Controlled Transient Elastography (VCTE®) at 50 Hz shear wave frequency and liver ultrasound attenuation coefficient (CAP™)* at 3.5 MHz. FibroScan® 630 Expert is also intended to measure spleen stiffness using VCTE® at 100 Hz shear wave frequency. FibroScan liver stiffness measurements (LSM) by VCTE® may aid the physician in determining the likelihood of cirrhosis and may be used, taken in context with other clinical and laboratory data, as an aid in the assessment of liver fibrosis. FibroScan CAP measurements may be used, taken in context with other clinical and laboratory data, as an aid in the assessment of hepatic steatosis. FibroScan® is indicated as a non-invasive aid for the clinical management, diagnosis, and monitoring of adult and pediatric patients with confirmed or suspected liver disease, as part of an overall assessment of the liver. Results in the pediatric population should be interpreted while considering the clinical condition and the overall patient profile. The FibroScan® device is intended for use by healthcare professionals in hospitals, clinics or any facility where healthcare is provided. *CAP refers to ultrasound attenuation coefficient (originally defined as Controlled Attenuation Parameter). CAP on S+ probe is only available with SmartExam capability. FibroScan® Gateway is a Non-Device Medical Device Data Systems (MDDS) and Interpretation Guide (included within myFibroScan application) are Non-Device Clinical Decision Support (CDS) that meet the criteria outlined in section 520(o)(1)(E) of the FD&C Act. © 2024 Echosens – Echosens™ and FibroScan® are trademarks owned by Echosens SA. All rights reserved. 

The Guided VCTE® technology is only available on the latest FibroScan® systems and can be used only with M+ and XL+ probes.